OBJECTIVE: To describe the variation in provision of hormonal and intrauterine contraception among Veterans Affairs (VA) facilities. DESIGN: Key informant, cross-sectional survey of 166 VA medical facilities. Data from public use data sets and VA administrative databases were linked to facility data to further characterize their contextual environments. PARTICIPANTS: All VA hospital-based and affiliated community-based outpatient clinics delivering services to at least 400 unique women during fiscal year 2000. MEASUREMENTS: Onsite availability of hormonal contraceptive prescription and intrauterine device (IUD) placement. RESULTS: Ninety-seven percent of facilities offered onsite prescription and management of hormonal contraception whereas 63% offered placement of IUDs. After adjusting for facility caseload of reproductive-aged women, 3 organizational factors were independently associated with onsite IUD placement: (1) onsite gynecologist (adjusted odds ratio [OR], 20.35; 95% confidence interval [CI], 7.02 to 58.74; P<.001); (2) hospital-based in contrast to community-based practice (adjusted OR, 5.49; 95% CI, 1.16 to 26.10; P=.03); and (3) availability of a clinician providing women's health training to other clinicians (adjusted OR, 3.40; 95% CI 1.19 to 9.76; P=.02). CONCLUSIONS: VA's provision of hormonal and intrauterine contraception is in accordance with community standards, although onsite availability is not universal. Although contraception is a crucial component of a woman's health maintenance, her ability to obtain certain contraceptives from the facility where she obtains her primary care is largely influenced by the availability of a gynecologist. Further research is needed to determine how fragmentation of women's care into reproductive and nonreproductive services impacts access to contraception and the incidence of unintended pregnancy.
OBJECTIVE: To describe the variation in provision of hormonal and intrauterine contraception among Veterans Affairs (VA) facilities. DESIGN: Key informant, cross-sectional survey of 166 VA medical facilities. Data from public use data sets and VA administrative databases were linked to facility data to further characterize their contextual environments. PARTICIPANTS: All VA hospital-based and affiliated community-based outpatient clinics delivering services to at least 400 unique women during fiscal year 2000. MEASUREMENTS: Onsite availability of hormonal contraceptive prescription and intrauterine device (IUD) placement. RESULTS: Ninety-seven percent of facilities offered onsite prescription and management of hormonal contraception whereas 63% offered placement of IUDs. After adjusting for facility caseload of reproductive-aged women, 3 organizational factors were independently associated with onsite IUD placement: (1) onsite gynecologist (adjusted odds ratio [OR], 20.35; 95% confidence interval [CI], 7.02 to 58.74; P<.001); (2) hospital-based in contrast to community-based practice (adjusted OR, 5.49; 95% CI, 1.16 to 26.10; P=.03); and (3) availability of a clinician providing women's health training to other clinicians (adjusted OR, 3.40; 95% CI 1.19 to 9.76; P=.02). CONCLUSIONS: VA's provision of hormonal and intrauterine contraception is in accordance with community standards, although onsite availability is not universal. Although contraception is a crucial component of a woman's health maintenance, her ability to obtain certain contraceptives from the facility where she obtains her primary care is largely influenced by the availability of a gynecologist. Further research is needed to determine how fragmentation of women's care into reproductive and nonreproductive services impacts access to contraception and the incidence of unintended pregnancy.
Authors: John C Fortney; Steven J Borowsky; Ashley N Hedeen; Matthew L Maciejewski; Michael K Chapko Journal: Med Care Date: 2002-07 Impact factor: 2.983
Authors: Michael K Chapko; Steven J Borowsky; John C Fortney; Ashley N Hedeen; Marsha Hoegle; Matthew L Maciejewski; Carol VanDeusen Lukas Journal: Med Care Date: 2002-07 Impact factor: 2.983
Authors: Ashley N Hedeen; Patrick J Heagerty; John C Fortney; Steven J Borowsky; Debby J Walder; Michael K Chapko Journal: Med Care Date: 2002-07 Impact factor: 2.983
Authors: Sonya Borrero; Lisa S Callegari; Xinhua Zhao; Maria K Mor; Florentina E Sileanu; Galen Switzer; Susan Zickmund; Donna L Washington; Laurie C Zephyrin; E Bimla Schwarz Journal: J Gen Intern Med Date: 2017-04-21 Impact factor: 5.128
Authors: Jodie Katon; Gayle Reiber; Danielle Rose; Bevanne Bean-Mayberry; Laurie Zephyrin; Donna L Washington; Elizabeth M Yano Journal: J Gen Intern Med Date: 2013-07 Impact factor: 5.128
Authors: Kwame K Adjei; Amos K Laar; Clement T Narh; Martha A Abdulai; Sam Newton; Seth Owusu-Agyei; Sam Adjei Journal: Reprod Health Date: 2015-08-08 Impact factor: 3.223